While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

The Enhanced Reconsideration System (ERS) is a production-grade AI memory management library designed to transform stateless AI agents into stateful ones. It integrates asynchronous promise chains, ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Officials estimate that pythons have killed 95% of small mammals as well as thousands of birds in Everglades National Park South Florida Water Management District via AP; AP Photo/Lynne Sladky ...

The Python Software Foundation warned users this week that threat actors are trying to steal their credentials in phishing attacks using a fake Python Package Index (PyPI) website. PyPI is a ...

Abstract: Nonlinear dynamical systems with oscillatory (periodic, quasi-periodic and chaotic) responses are analyzed in this paper through the method of Lyapunov exponents. The main goal is to present ...

Running Python scripts is one of the most common tasks in automation. However, managing dependencies across different systems can be challenging. That’s where Docker comes in. Docker lets you package ...

Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical success. The recent cull of programs has further undermined investor ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

Five Jewish senators, including Democratic leader Chuck Schumer, have signed a letter accusing the Trump administration of using antisemitism as a “guise” to attack universities. The letter from the ...

Recursion, a clinical-stage TechBio company, is set to present preliminary data from its Phase 1b/2 clinical trial, TUPELO, at the 2025 Digestive Disease Week (DDW) meeting on May 4, 2025, in San ...